Vitamin D and Prostate Cancer
Open Access
- 2 January 2002
- journal article
- review article
- Published by Wiley in Journal of Andrology
- Vol. 23 (1) , 9-17
- https://doi.org/10.1002/j.1939-4640.2002.tb02596.x
Abstract
Click on the article title to read more.Keywords
This publication has 77 references indexed in Scilit:
- EFFECTS OF VITAMIN D (CALCITRIOL) ON TRANSITIONAL CELL CARCINOMA OF THE BLADDER IN VITRO AND IN VIVOJournal of Urology, 2001
- Maximal androgen blockade: facts and fallaciesEndocrine-Related Cancer, 1998
- Maximal androgen withdrawal for prostate cancer therapy: current status and future potentialEndocrine-Related Cancer, 1998
- Induction of Apoptosis and Altered Nuclear/Cytoplasmic Distribution of the Androgen Receptor and Prostate-Specific Antigen by 1α,25-Dihydroxyvitamin D3in Androgen-Responsive LNCaP CellsBiochemical and Biophysical Research Communications, 1997
- 1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Non-hypercalcemic pharmacological aspects of vitamin D analogsBiochemical Pharmacology, 1995
- IGF‐Binding proteins in human prostate tumor cells: Expression and regulation by 1,25‐dihydroxyvitamin D3The Prostate, 1995
- POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATIONThe Lancet, 1989
- Aging decreases the capacity of human skin to produce vitamin D3.Journal of Clinical Investigation, 1985
- Latent Prostatic Cancer in a Consecutive Autopsy SeriesScandinavian Journal of Urology and Nephrology, 1980